DOES GABAPENTIN AND LAMOTRIGINEL HAVE SIGNIFICANTLY FEWER SIDE-EFFECTS WHILE PROVIDING EQUAL OR BETTER SEIZURE CONTROL THAN THE CURRENT DRUG CHOICE, CARBAMAZEPINE, FOR THE TREATMENT OF SEIZURES IN THE ELDERLY.: